Solenic Medical, Inc.
Solenic Medical Inc. is pioneering a non-invasive solution for infected metallic implants using patented alternating magnetic field (AMF) technology. Their mission is to eradicate biofilms on implant surfaces, effectively treating a common and costly surgical complication, with the goal of replacing risky and expensive revision surgeries and transforming the standard of care.
Industries
Nr. of Employees
small (1-50)
Solenic Medical, Inc.
4275 Kellway Circle, Suite 146, Addison, Texas 75001
Products
First‑generation investigational AMF knee system
Investigational, non‑contact device system designed to deliver alternating magnetic fields to compatible metallic knee implant components to thermally target biofilm in an operating room setting.
First‑generation investigational AMF knee system
Investigational, non‑contact device system designed to deliver alternating magnetic fields to compatible metallic knee implant components to thermally target biofilm in an operating room setting.
Services
Conduct and manage FDA-approved investigational device studies for AMF treatment of total knee implant infections, including site coordination and patient enrollment in limited-scope trials.
Design and execution of GLP-compliant large-animal studies and preclinical experiments to evaluate AMF efficacy, safety, and combination therapies for implant-associated infections.
Advisory services in quality management system development and regulatory strategy for device development and submissions based on internal regulatory experience.
Conduct and manage FDA-approved investigational device studies for AMF treatment of total knee implant infections, including site coordination and patient enrollment in limited-scope trials.
Design and execution of GLP-compliant large-animal studies and preclinical experiments to evaluate AMF efficacy, safety, and combination therapies for implant-associated infections.
Advisory services in quality management system development and regulatory strategy for device development and submissions based on internal regulatory experience.
Expertise Areas
- Orthopedic implant infection treatment
- Clinical trial design and execution (IDE/early feasibility)
- Medical device electromagnetic engineering
- Preclinical large‑animal implant models
Key Technologies
- Alternating magnetic field (AMF) induction heating
- Electromagnetic coil and field shaping
- Thermal dosimetry and computational modeling
- Infrared thermal imaging
News & Updates
Solenic Medical Inc. won the Industry Innovation Award at the 2024 annual meeting of the American Association of Hip and Knee Surgeons (AAHKS) held in Dallas TX, from November 8th to the 9th. The award recognized their patented technology using alternating magnetic fields (AMF) to generate thermal medical on the surface of the implants, aiming to eradicate biofilms.
Solenic Medical Inc. was selected as one of the highest scoring pitches at the Redefining Early Stage Investments (RESI) Boston event presented by Life Science Nation. The event featured 56 innovative companies, and Solenic was recognized for their high-quality pitch and clear communication of their value.
Solenic Medical Inc. won the Best Scientific Poster Award at the 35th International Society of Technology in Arthroplasty (ISTA) conference in Nashville, TN. The poster highlighted the safety, efficacy, and validation of AMF heating on a primary knee implant and surrounding tissues using human cadaver and digital knee models.
Solenic Medical announced the successful treatment of its first patient as part of its early feasibility clinical trial utilizing its groundbreaking, investigational Alternating Magnetic Field (AMF) technology.
Solenic Medical announced the addition of three distinguished experts to its advisory boards to advance medical innovation and strategic growth.
Solenic Medical announced that it has received Breakthrough Device designation from the U.S. Food and Drug Administration (FDA) for its AMF device, which may provide more effective treatment of life-threatening or debilitating conditions.
Solenic Medical Inc. won the Industry Innovation Award at the 2024 annual meeting of the American Association of Hip and Knee Surgeons (AAHKS) held in Dallas TX, from November 8th to the 9th. The award recognized their patented technology using alternating magnetic fields (AMF) to generate thermal medical on the surface of the implants, aiming to eradicate biofilms.
Solenic Medical Inc. was selected as one of the highest scoring pitches at the Redefining Early Stage Investments (RESI) Boston event presented by Life Science Nation. The event featured 56 innovative companies, and Solenic was recognized for their high-quality pitch and clear communication of their value.
Solenic Medical Inc. won the Best Scientific Poster Award at the 35th International Society of Technology in Arthroplasty (ISTA) conference in Nashville, TN. The poster highlighted the safety, efficacy, and validation of AMF heating on a primary knee implant and surrounding tissues using human cadaver and digital knee models.
Solenic Medical announced the successful treatment of its first patient as part of its early feasibility clinical trial utilizing its groundbreaking, investigational Alternating Magnetic Field (AMF) technology.
Solenic Medical announced the addition of three distinguished experts to its advisory boards to advance medical innovation and strategic growth.
Solenic Medical announced that it has received Breakthrough Device designation from the U.S. Food and Drug Administration (FDA) for its AMF device, which may provide more effective treatment of life-threatening or debilitating conditions.